Kindly MD (KDLY) Competitors $2.36 -0.63 (-21.07%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.30 -0.06 (-2.75%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends KDLY vs. ENZ, CCM, BRTX, MRAI, MGRX, OPGN, OTRK, BGLC, SSY, and DHACShould you be buying Kindly MD stock or one of its competitors? The main competitors of Kindly MD include Enzo Biochem (ENZ), Concord Medical Services (CCM), BioRestorative Therapies (BRTX), Marpai (MRAI), Mangoceuticals (MGRX), OpGen (OPGN), Ontrak (OTRK), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), and Digital Health Acquisition (DHAC). These companies are all part of the "healthcare" industry. Kindly MD vs. Enzo Biochem Concord Medical Services BioRestorative Therapies Marpai Mangoceuticals OpGen Ontrak BioNexus Gene Lab SunLink Health Systems Digital Health Acquisition Kindly MD (NASDAQ:KDLY) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment. Which has preferable earnings & valuation, KDLY or ENZ? Kindly MD has higher earnings, but lower revenue than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindly MDN/AN/AN/AN/AN/AEnzo Biochem$31.91M0.84-$26.08MN/AN/A Does the media prefer KDLY or ENZ? In the previous week, Enzo Biochem had 1 more articles in the media than Kindly MD. MarketBeat recorded 1 mentions for Enzo Biochem and 0 mentions for Kindly MD. Enzo Biochem's average media sentiment score of 0.46 beat Kindly MD's score of 0.00 indicating that Enzo Biochem is being referred to more favorably in the news media. Company Overall Sentiment Kindly MD Neutral Enzo Biochem Neutral Does the MarketBeat Community favor KDLY or ENZ? Enzo Biochem received 212 more outperform votes than Kindly MD when rated by MarketBeat users. CompanyUnderperformOutperformKindly MDN/AN/AEnzo BiochemOutperform Votes21253.67% Underperform Votes18346.33% Do insiders & institutionals believe in KDLY or ENZ? 36.9% of Enzo Biochem shares are held by institutional investors. 50.5% of Kindly MD shares are held by company insiders. Comparatively, 11.4% of Enzo Biochem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is KDLY or ENZ more profitable? Kindly MD has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. Kindly MD's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets Kindly MDN/A N/A N/A Enzo Biochem -75.34%-7.96%-5.49% SummaryEnzo Biochem beats Kindly MD on 5 of the 9 factors compared between the two stocks. Get Kindly MD News Delivered to You Automatically Sign up to receive the latest news and ratings for KDLY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KDLY vs. The Competition Export to ExcelMetricKindly MDHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.87M$1.04B$5.84B$9.15BDividend YieldN/A2.04%4.75%3.85%P/E RatioN/A48.1225.4719.00Price / SalesN/A3.71447.5876.30Price / CashN/A26.1438.0134.83Price / BookN/A2.937.644.62Net IncomeN/A-$5.50M$3.18B$245.85M7 Day Performance-18.34%-6.70%-1.99%-2.68%1 Month Performance61.09%2.94%-0.42%-2.19%1 Year PerformanceN/A87.63%16.51%12.84% Kindly MD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KDLYKindly MDN/A$2.36-21.1%N/AN/A$17.87MN/A0.00N/AENZEnzo Biochem1.5128 of 5 stars$0.54-2.9%N/A-61.2%$28.42M$31.91M0.00520Analyst ForecastNews CoverageCCMConcord Medical Services0.6092 of 5 stars$5.06-1.9%N/A-36.2%$21.98M$471.70M0.00970Analyst ForecastNews CoverageGap DownBRTXBioRestorative Therapies3.1628 of 5 stars$2.37+3.0%$18.00+659.5%+32.0%$16.30M$150,000.00-1.547News CoverageMRAIMarpaiN/A$0.95+3.3%$6.00+531.6%-33.0%$13.76M$37.15M-0.36150Gap DownMGRXMangoceuticals0.813 of 5 stars$4.11-3.3%N/A-91.2%$10.35M$730,000.00-0.723News CoverageGap UpHigh Trading VolumeOPGNOpGenN/A$1.20-8.4%N/A-70.2%$10.03M$3.42M0.00100Analyst ForecastOTRKOntrak3.1525 of 5 stars$1.63-0.3%$45.00+2,669.2%-49.4%$6.86M$12.74M-0.15250Analyst RevisionNews CoverageGap UpBGLCBioNexus Gene LabN/A$0.38-1.3%N/A-53.2%$6.83M$9.77M0.0030SSYSunLink Health SystemsN/A$0.93+0.5%N/A+18.5%$6.51M$32.44M-8.411,376Analyst ForecastGap DownDHACDigital Health AcquisitionN/A$1.76+0.6%N/A-84.6%$6.34MN/A0.002,021Gap UpHigh Trading Volume Related Companies and Tools Related Companies Enzo Biochem Alternatives Concord Medical Services Alternatives BioRestorative Therapies Alternatives Marpai Alternatives Mangoceuticals Alternatives OpGen Alternatives Ontrak Alternatives BioNexus Gene Lab Alternatives SunLink Health Systems Alternatives Digital Health Acquisition Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KDLY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kindly MD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kindly MD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KDLY Stock Alerts